OCF Yield % is calculated as Cash Flow from Operations divided by Market Capitalization. It is a financial solvency ratio that compares the operating cash flow a company is expected to earn against its market value.
Similar to Earnings Yield %, OCF Yield % is financial solvency ratio. A lower ratio suggests a less attractive investment, indicating that investors might not receive substantial returns in proportion to their investment. Conversely, a high operating cash flow yield signals that a company generates sufficient cash to comfortably meet its debts, obligations, and dividend payments, making it a promising investment choice.
Kilitch Drugs (India) OCF Yield % Related Terms
Kilitch Drugs (India) OCF Yield % Historical Data
* Premium members only.
The historical data trend for Kilitch Drugs (India)'s OCF Yield % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Drug Manufacturers - Specialty & Generic subindustry, Kilitch Drugs (India)'s OCF Yield %, along with its competitors' market caps and OCF Yield % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Kilitch Drugs (India) OCF Yield % vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Kilitch Drugs (India)'s OCF Yield % distribution charts can be found below:
* The bar in red indicates where Kilitch Drugs (India)'s OCF Yield % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Kilitch Drugs (India) (NSE:KILITCH) has a OCF Yield % of 3.73 as of Jul. 03, 2026. OCF Yield is calculated as Cash Flow from Operations divided by Market Capitalization. View historical data on Kilitch Drugs (India) and its competitors. Over the past decade, Kilitch Drugs (India)'s OCF Yield % has ranged from 3.73 to 3.73. According to the industry distribution chart, Kilitch Drugs (India) ranks #485 out of 1007 companies in the Drug Manufacturers industry, placing it in the top 48.2%.
Is Kilitch Drugs (India)'s OCF Yield % too high?
Kilitch Drugs (India)'s current OCF Yield % is 3.73. Over the past 10 years, this metric has ranged from a low of 3.73 to a high of 3.73. The Drug Manufacturers industry median OCF Yield % is 3.43. Kilitch Drugs (India)'s value of 3.73 is 8.7% above this industry median. Based on the distribution chart, Kilitch Drugs (India) ranks #485 out of 1007 companies in the Drug Manufacturers industry, which is above the industry midpoint. Overall, Kilitch Drugs (India) has a GF Score™ of 83/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Kilitch Drugs (India)'s OCF Yield % compare to ZTS and UTHR?
According to the Drug Manufacturers industry distribution chart, Kilitch Drugs (India) ranks #485 out of 1007 companies for OCF Yield %. This puts Kilitch Drugs (India) in the upper half of its industry. The industry median OCF Yield % is 3.43. Kilitch Drugs (India)'s value of 3.73 is 8.7% above this benchmark. Historically, Kilitch Drugs (India)'s own OCF Yield % has ranged from 3.73 to 3.73 over the past decade. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good OCF Yield % for a Drug Manufacturers company?
The median OCF Yield % among Drug Manufacturers companies is 3.43, based on 1,007 companies in the industry. Companies in the top quartile (top 25%) have a OCF Yield % significantly above this median, while those in the bottom quartile fall well below. However, OCF Yield % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Kilitch Drugs (India)'s current OCF Yield % of 3.73 is 8.7% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high OCF Yield % mean?
A high OCF Yield % can signal that a stock is expensive relative to its fundamentals. OCF Yield is calculated as Cash Flow from Operations divided by Market Capitalization. View historical data on Kilitch Drugs (India) and its competitors. For the Drug Manufacturers industry, the median OCF Yield % is 3.43 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Kilitch Drugs (India)'s current OCF Yield % is 3.73. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Kilitch Drugs (India) stock overvalued right now?
Based on GuruFocus' analysis, Kilitch Drugs (India) (NSE:KILITCH) is currently considered Modestly Undervalued. The stock's GF Value™ is ₹225.80, compared to a current price of ₹196.99 — trading 12.8% below its estimated fair value. The current OCF Yield % is 3.73 and 8.7% above the Drug Manufacturers industry median of 3.43. Kilitch Drugs (India)'s overall GF Score™ is 83/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is OCF Yield % calculated?
OCF Yield % is calculated from a company's financial statements. For Kilitch Drugs (India) (NSE:KILITCH), the current OCF Yield % is 3.73 as of Jul. 03, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Kilitch Drugs (India) (NSE:KILITCH) Overvalued in 2026?
Based on GuruFocus' analysis, Kilitch Drugs (India) stock appears to be undervalued.
The current stock price of ₹196.99 is trading 12.8% below its estimated GF Value™ of ₹225.80.
GuruFocus considers Kilitch Drugs (India) to be Modestly Undervalued.
Key valuation signals for NSE:KILITCH:
OCF Yield %: 3.73
GF Value™: ₹225.80 vs. price of ₹196.99 (12.8% below fair value)
Industry Position: 8.7% above the Drug Manufacturers median (#485 of 1007)
No single metric tells the full story. See the NSE:KILITCH stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Kilitch Drugs (India) Ltd is an India-based pharmaceutical company. It is engaged in operation and management of Pharmaceutical Products. The company offers parenteral and nasal products, oral formulations, effervescent tablets, nutritional products, medical devices, and cosmetic and health products. Some of the products offered by the company are Roipar, Roivit, PH-7, C-Seal, SRO kit, 9-VIT, and HPURE. The company has one reportable segment, which is the development and operations of the Pharmaceutical business.
83GF Score
Get the complete analysis for NSE:KILITCH
OCF Yield % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
NSE:KILITCH has been successfully added to your 
